The ban means only tobacco, mint and menthol flavors can be sold at
these outlets, the agency official said, potentially dealing a major
blow to Juul Labs Inc, the San Francisco-based market leader in vape
devices.
The FDA also will introduce stricter age-verification requirements
for online sales of e-cigarettes. The FDA’s planned restrictions,
first reported by The Washington Post and confirmed to Reuters by
the official, do not apply to vape shops or other specialty retail
stores.
There has been mounting pressure for action after preliminary
federal data showed teenage use had surged by more than 75 percent
since last year, and the FDA has described it as an "epidemic".
"E-cigs have become an almost ubiquitous ‒ and dangerous ‒ trend
among teens," FDA Commissioner Scott Gottlieb said in September.
"The disturbing and accelerating trajectory of use we're seeing in
youth, and the resulting path to addiction, must end. It's simply
not tolerable."
That growth has coincided with the rise of Juul, whose sales of
vaping devices grew from 2.2 million in 2016 to 16.2 million devices
last year, according to the U.S. Centers for Disease Control and
Prevention.
The agency threatened in September to ban Juul and four other
leading e-cigarette products unless their makers took steps to
prevent use by minors. The FDA gave Juul and four big tobacco
companies 60 days to submit plans to curb underage use, a compliance
period that is now ending.
The planned restrictions on flavors in convenience stores are likely
to have the biggest impact on Juul, which sells nicotine liquid pods
in flavors such as mango, mint, fruit and creme, previously called
creme brulee.
The only other e-cigarette competitors sold at convenience stores
are those marketed primarily by tobacco companies such as Altria
Group Inc, British American Tobacco Plc, Imperial Brands Plc and
Japan Tobacco Inc .
Those products, sold under the MarkTen, blu, Vuse and Logic brands,
have lost market share as Juul has risen to prominence over the last
year, growing from 13.6 percent of the U.S. e-cigarette market in
early 2017 to nearly 75 percent now, according to a Wells Fargo
analysis of Nielsen retail data.
[to top of second column] |
E-cigarette products represent a small share of revenue for major
tobacco companies, whereas Juul’s business is built entirely on the
vaping devices. Revenue from e-cigarette devices made up less than 1
percent of British American Tobacco’s global revenue for the first
six months of 2018, according to a company filing from July.
Altria last month announced it would stop selling its pod-based
electronic cigarettes, generally smaller devices that use pre-filled
nicotine liquid cartridges, in response to the FDA’s concerns about
teen usage. The company also said it would restrict flavors for its
other e-cigarette products to tobacco, menthol and mint.
Representatives from Altria, British American Tobacco, Imperial
Brands and Japan Tobacco did not respond to requests for comment
Thursday evening. A Juul spokeswoman declined to comment.
The companies have previously said their products are intended for
adult use and that they work to ensure retailers comply with the
law.
Juul has previously said the company wants to be "part of the
solution in keeping e-cigarettes out of the hands of young people"
but that "appropriate flavors play an important role in helping
adult smokers switch."
Meredith Berkman, a founder of Parents Against Vaping E-cigarettes,
which seeks to curb underage use, said the agency’s move was a “good
first step," but added that "the final step should have happened
yesterday."
"Why not do away with flavors altogether, why not do away with
online sales altogether?" she said.
E-cigarettes have been a divisive topic in the public health
community. Some focus on the potential for the products to shift
lifelong smokers onto less harmful nicotine products, while others
fear they risk drawing a new generation into nicotine addiction.
Last year the FDA, under Gottlieb, extended until 2022 a deadline
for e-cigarette companies to comply with new federal rules on
marketing and public health.
(Reporting by Chris Kirkham; Editing by Simon Cameron-Moore)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |